Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$98.98 - $115.74 $1.47 Million - $1.72 Million
14,898 Added 4.76%
327,898 $37.9 Million
Q2 2023

Aug 11, 2023

SELL
$96.34 - $112.38 $5.9 Million - $6.89 Million
-61,293 Reduced 16.38%
313,000 $32.2 Million
Q1 2023

May 10, 2023

BUY
$107.32 - $113.5 $1.26 Million - $1.33 Million
11,707 Added 3.23%
374,293 $40.9 Million
Q4 2022

Feb 13, 2023

BUY
$62.39 - $113.8 $4.12 Million - $7.52 Million
66,068 Added 22.28%
362,586 $41.3 Million
Q3 2022

Nov 10, 2022

SELL
$58.92 - $84.67 $495,281 - $711,736
-8,406 Reduced 2.76%
296,518 $18.4 Million
Q2 2022

Aug 12, 2022

SELL
$79.4 - $116.36 $8.47 Million - $12.4 Million
-106,635 Reduced 25.91%
304,924 $24.3 Million
Q1 2022

May 16, 2022

BUY
$86.42 - $109.81 $421,556 - $535,653
4,878 Added 1.2%
411,559 $43.3 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $1.64 Million - $1.99 Million
16,630 Added 4.26%
406,681 $43.8 Million
Q3 2021

Nov 12, 2021

BUY
$91.91 - $110.37 $458,814 - $550,967
4,992 Added 1.3%
390,051 $42.7 Million
Q2 2021

Aug 16, 2021

BUY
$86.24 - $95.92 $12.6 Million - $14 Million
145,762 Added 60.91%
385,059 $36.1 Million
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $315,261 - $419,061
-4,389 Reduced 1.8%
239,297 $22 Million
Q4 2020

Feb 12, 2021

BUY
$67.0 - $84.39 $4.48 Million - $5.64 Million
66,844 Added 37.8%
243,686 $17.8 Million
Q3 2020

Nov 13, 2020

SELL
$55.23 - $79.93 $2.53 Million - $3.66 Million
-45,763 Reduced 20.56%
176,842 $13.7 Million
Q2 2020

Aug 12, 2020

SELL
$30.2 - $56.98 $3.1 Million - $5.84 Million
-102,498 Reduced 31.53%
222,605 $12.4 Million
Q1 2020

May 13, 2020

BUY
$24.87 - $38.56 $3.54 Million - $5.49 Million
142,454 Added 77.99%
325,103 $9.63 Million
Q4 2019

Feb 12, 2020

BUY
$25.43 - $36.67 $894,398 - $1.29 Million
35,171 Added 23.85%
182,649 $6.61 Million
Q3 2019

Nov 12, 2019

SELL
$23.0 - $27.97 $2.4 Million - $2.92 Million
-104,458 Reduced 41.46%
147,478 $4.02 Million
Q2 2019

Aug 14, 2019

BUY
$22.81 - $28.48 $5.75 Million - $7.18 Million
251,936 New
251,936 $6.06 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Credit Suisse Ag Portfolio

Follow Credit Suisse Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.